• Home
  • 2.0 LPBI Executive Summary
  • 1.0 LPBI Executive Summary
  • Journal PharmaceuticalIntelligence.com
  • Portfolio of IP Assets
  • Knowledge PORTALS System (KPS)
  • 1.0 LPBI – 2012-2020 VISTA
  • LPBI Group’s History
  • 2.0 LPBI – 2021-2025 VISION
  • BioMed e-Series
  • Press Coverage
  • Investor Relations
  • Our TEAM
  • Founder
  • Funding, Deals & Partnerships
  • 1.0 LPBI Group News
  • 1.0 LPBI CALENDAR
  • 2.0 LPBI Group News
  • Testimonials about LPBI
  • DrugDiscovery @LPBI Group
  • Medical 3D Printing
  • e-VOICES Podcasting
  • LPBI Newsletters
  • Customer Surveys
  • Health Care INVESTOR’s Corner ($)
  • 2021 Summer Internship Portal
  • 2021-2022 Medical Text Analysis (NLP)
  • Artificial Intelligence: Genomics & Cancer
  • SOP Web STAT
  • Blockchain Transactions Network Ecosystem
  • Contact Us
  • 1.0 LPBI Brochure
  • 2.0 LPBI Brochure
  • 2.0 LPBI – Calendar of Zooms
  • Coronavirus, SARS-CoV-2 Portal
  • LPBI India
  • Synthetic Biology in Drug Discovery
  • Certificate One Year
  • NFT: Redefined Format of IP Assets
  • Audio English-Spanish: BioMed e-Series
  • Five Bilingual BioMed e-Series
  • Press Releases
  • Intangibles CIM

Leaders in Pharmaceutical Business Intelligence (LPBI) Group

Funding, Deals & Partnerships: BIOLOGICS & MEDICAL DEVICES; BioMed e-Series; Medicine and Life Sciences Scientific Journal – http://PharmaceuticalIntelligence.com

Feeds:
Posts
Comments

WHAT ARE LPBI Group’s NEEDS in June 2019: Aviva’s BOLD VISION on June 11, 2019

WHAT ARE LPBI Group’s NEEDS in June 2019

Aviva’s BOLD VISION on June 11, 2019

 

 

Task 1:   Artificial Intelligence in Medicine

– Weekly engagement

https://www.aiin.healthcare

 

Majority of healthcare organizations are testing out AI

June 05, 2019 | Amy Baxter | Connected Care

https://www.aiin.healthcare/topics/connected-

care/majority-healthcare-organizations-are-

testing-out-ai?utm_source=newsletter&utm_medium=cvb_news

 

Task 2:   Promotion of BioMed e-Series to Med Schools

– Monthly engagement

 

Task 3:   Going DIRECT for finding an M&A partner

– Quarterly engagement

 

Team Member Task Assignment

 

FIT Member Task 1:

AI in Medicine

https://www.aiin.healthcare

 Task 2:

BioMed e-Series introduction to Med Schools
Science

Team

 Weekly ONE page post on AI in Medicine Monthly milestones two schools send e-mail to Specialty Faculty Members on ONE series

July 15, 2019 report
Dr. Irina Robu Yes – AI in Pathology Series E in Canada
Dr. Sudipta Saha Yes – AI in Biological Sciences Series D

in India
Dr. Dror Nir

________

 

Dr. Justin Pearlman

 Yes – AI in Medical Imaging

Ultrasound, MRI, CT, CTA

Yes – AI in Robotics-assisted Surgery

 Series C 

UK

_________

Series A

MA, NH
Dr. Stephen J. Williams Yes – AI in Cancer Series B & C

PA & MD
Prof. Feldman Yes – AI Technologies and Methodologies All Series

OR

AZ
Aviva Yes – CVD All Series

MA
Business

Team

 Weekly ONE page post on AI in Medicine
Gail AI in Health care Series E

NJ
Amnon AI in Biotech FIN Series E

ISRAEL
Rick AI in HealthIT Series B

UT
Aviva

 

___________

 AI in Diagnostics Series A

Japan
Non-Active:

  • Dr. Larry,
  • Adam
 Snooze mode

 

 

WHAT ARE LPBI Group’s NEEDS in June 2019

Aviva’s BOLD VISION on June 11, 2019 – Continued

 

 

Task 3:   Going DIRECT for finding an M&A partner

– Quarterly engagement

 

Team Member Task Assignment

 

FIT Member Task 3:

Niche Playing to find DIRECTLY M&A partner

 Specials
Science

Team

 Quarterly report – October 1, 2019  
Dr. Irina Robu Pharma or Education  
Dr. Sudipta Saha India Academic Publishing  
Dr. Dror Nir Big MedTech Equipment GE, Siemens, Phillips  
Dr. Stephen J. Williams One of these three:

  • Big Pharma – Top 20 R&D & Ventures
  • HealthCare Insurers – US
  • Geisinger Medical Center, Lancaster, PA

 

 7/15/19 start Genomics Vol 2

November 1, Submit to Aviva

________
Prof. Feldman Australia & New Zealand potentially interested parties in the Journal, Books, eProceedings 7/15/19 start Genomics Vol 2

November 1, Submit to Aviva

________
Aviva

&

Dr. Pearlman

 UK – Media

Germany – Academic Publishing

 Aviva needs to Finish Genomics Vol 2

to be published in 2019
Business

Team

 Quarterly report – October 1, 2019
Gail Global Media & Publishing Players Clarivate – Reuters

https://clarivate.com/
Amnon Choose three of the GLOBAL FIN to find M&A for LPBI Group IP Assets

https://pitchbook.com/news/search?media-types=AR&tags=top-investor

 
Rick Private equity in health care:

Choose three of the FIN to find M&A for LPBI Group IP Assets

 
Aviva

 

_________

 Europe – focus  
Non-Active:

  • Dr. Larry
  • Adam

 

 

Share this:

  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to print (Opens in new window)
  • Click to email a link to a friend (Opens in new window)

Like this:

Like Loading...

  • Follow Blog via Email

    Enter your email address to follow this blog and receive notifications of new posts by email.

    Join 9,459 other subscribers

  • Recent Posts

    • Creating a Twitter Space for @pharma_BI for Live Broadcasts March 14, 2023
    • The Vibrant Philly Biotech Scene: Recent Happenings & Deals March 11, 2023
    • Peak oxygen uptake (VO2peak) quantified fitness: Lifelong and late-onset athletes had higher VO2peak than non-athletes March 7, 2023
    • Merck’s sotatercept overachieves, PCSK9 inhibitor passes phase 2 March 6, 2023
    • Bacterial multidrug resistance problem solved by a broad-spectrum synthetic antibiotic March 1, 2023
    • Genetic variation causes human lupus, systemic lupus erythematosus (SLE) February 23, 2023
    • Mimicking vaginal cells and microbiome interactions on chip microfluidic culture February 14, 2023
    • Press Release for Five Bilingual BioMed e-Series in English and in Spanish January 29, 2023
    • 2022 FDA Drug Approval List, 2022 Biological Approvals and Approved Cellular and Gene Therapy Products January 17, 2023
    • Verily announced other organizational changes, 1/13/2023 January 16, 2023

  • Archives

  • Categories

  • Meta

    • Log in
    • Entries feed
    • Comments feed
    • WordPress.org

    • 1 2012pharmaceutical
    • 1 Amandeep Kaur
    • 1 Aashir Awan, Phd
    • 1 Abhisar Anand
    • 1 Adina Hazan
    • 1 Alan F. Kaul, PharmD., MS, MBA, FCCP
    • 1 alexcrystal6
    • 1 anamikasarkar
    • 1 apreconasia
    • 1 aviralvatsa
    • 1 David Orchard-Webb, PhD
    • 1 danutdaagmailcom
    • 1 Demet Sag, Ph.D., CRA, GCP
    • 1 Dror Nir
    • 1 dsmolyar
    • 1 Ethan Coomber
    • 1 evelinacohn
    • 1 Gail S Thornton
    • 1 Irina Robu
    • 1 jayzmit48
    • 1 jdpmd
    • 1 jshertok
    • 1 kellyperlman
    • 1 Ed Kislauskis
    • 1 larryhbern
    • 1 Madison Davis
    • 1 marzankhan
    • 1 megbaker58
    • 1 ofermar2020
    • 1 Dr. Pati
    • 1 pkandala
    • 1 ritusaxena
    • 1 Rick Mandahl
    • 1 sjwilliamspa
    • 1 Srinivas Sriram
    • 1 stuartlpbi
    • 1 Dr. Sudipta Saha
    • 1 tildabarliya
    • 1 vaishnavee24
    • 1 zraviv06
    • 1 zs22

Powered by WordPress.com.

WPThemes.


%d bloggers like this: